The global surge in high-definition video consumption, real-time remote collaboration, and IoT-integrated surveillance has placed unprecedented pressure on network infrastructures. At the heart of ...

How exactly did basketball's greatest viral sensation end up spending the winter in Hoffman Estates? The answer isn't complicated. Guard Mac McClung, famous for winning three NBA dunk contests, had ...

Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special ...

Abeona Therapeutics (ABEO) stock gets a "Buy" rating, driven by ZEVASKYN's commercial launch for RDEB and strong early demand signals. Read the full analysis here.

BASF SE’s BASFY Agricultural Solutions is strengthening its position as a global leader in canola advancement through a €17 million investment to expand and transform its Canola Breeding Centre of ...

Life-saving treatments for children with orphan illnesses often move slowly, if at all, through the federal approval process.

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

Haunted by the cystic fibrosis patients he could not help, one Iowa doctor commits his life to understanding what is broken deep inside their cells.

Learn more about whether Revvity, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Kidney cancer is the sixth most common cancer in the UK but, as there aren't many symptoms, it's hard to diagnose ...

LaVeda Hicks, 72, of Grampian, is really looking forward to an upcoming trip when she can board an airplane and fasten her ...

Manchester United's academy director explains how he plans to improve what has come before at a club "built on youth" ...